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Understanding human embryonic ventral midbrain
is of major interest for Parkinson’s disease. However,
the cell types, their gene expression dynamics,
and their relationship to commonly used rodent
models remain to be defined. We performed single-
cell RNA sequencing to examine ventral midbrain
development in human and mouse. We found
25 molecularly defined human cell types, including
five subtypes of radial glia-like cells and four progen-
itors. In the mouse, two mature fetal dopaminergic
neuron subtypes diversified into five adult classes
during postnatal development. Cell types and gene
expression were generally conserved across spe-
cies, but with clear differences in cell proliferation,
developmental timing, and dopaminergic neuron
development. Additionally, we developed a method
to quantitatively assess the fidelity of dopaminergic
neurons derived from human pluripotent stem
cells, at a single-cell level. Thus, our study provides
insight into the molecular programs controlling
human midbrain development and provides a foun-
dation for the development of cell replacement
therapies.INTRODUCTION
Much of our current knowledge about brain development is
based on the rodent brain. In the embryonic mouse ventricular
zone (VZ), neuroepithelial stem cells differentiate into radial glia
that will generate neurons, astrocytes, oligodendrocytes, and
ependymal cells in successive waves of differentiation (Shen
et al., 2006). Analysis of mutant mice has revealed that
morphogens such as WNT/b-catenin, SHH, and FGF8 induce566 Cell 167, 566–580, October 6, 2016 ª 2016 The Author(s). Publis
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boundary that provide nascent neuroblasts with defined dorso-
ventral, antero-posterior, and mediolateral identities (Arenas
et al., 2015). As a result, these neuroblasts mature into spatially
defined mature populations, including dopaminergic neurons,
oculomotor and trochlear neurons, and red nucleus neurons.
The adult midbrain contains two main anatomically defined
populations of dopaminergic neurons, located in the ventral
tegmental area (VTA) and in the substantia nigra pars compacta
(SNc) (Bjo¨rklund and Dunnett, 2007). Notably, SNc neurons
degenerate in Parkinson’s disease while the VTA suffers only
a 40% reduction (Damier et al., 1999; Javoy-Agid and Agid,
1980).
The development of the human ventral midbrain is currently
thought to follow a similar sequence of events and principles
as in rodent. However, the cell type composition and develop-
mental programs that control the human ventral midbrain are
largely unknown. It is also unclear what is the degree of conser-
vation between mouse and human midbrain development and
whether all cell types in human even have unambiguous counter-
parts in the mouse. In addition, several fundamental questions
remain to be elucidated. First, it is unclear whether a single cell
type (radial glia; Bonilla et al., 2008) can give rise to all the diverse
progeny found in the ventral midbrain. Second, although five
molecularly distinct dopaminergic neuron types have been
recently described in the adult mouse (Poulin et al., 2014), it is
unclear if these are specified in the embryo (e.g., using patterning
morphogens) or if they emerge only postnatally (e.g., as a result
of local environmental cues or feedback from innervation
targets).
Single-cell RNA-sequencing (RNA-seq) has been previously
used for de novo cell type discovery in multiple tissues (Pollen
et al., 2014, 2015; Treutlein et al., 2014; Zeisel et al., 2015; Mar-
ques et al., 2016). Here, we use single-cell RNA-seq to examine
ventral midbrain development in both mouse and human. Our
results provide an unbiased classification of cell types and
their gene expression patterns during human and mouse ventral
midbrain development.hed by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. Cell Populations and their Distribution Over Time during Human and Mouse Ventral Midbrain Development
(A) Overview of the time points sampled for human and mouse embryos. E, embryonic day; P, postnatal day; w, week.
(B) Illustration of the workflow of the experiment and the region dissected.
(C) Molecularly defined cell types of the human embryonicmidbrain. Dot plot shows time distribution of cell types, heatmap shows pairwise correlations, and bars
show average number of detectedmRNAmolecules per cell. Cell types are named using anatomical and functional mnemonics prefixed by ‘‘m’’ or ‘‘h’’ to indicate
mouse and human respectively: OMTN, oculomotor and trochlear nucleus; Sert, serotonergic; NbM, medial neuroblast; NbDA, neuroblast dopaminergic; DA0-2,
dopaminergic neurons; RN, red nucleus; Gaba1-2, GABAergic neurons; mNbL1-2, lateral neuroblasts; NbML1-5, mediolateral neuroblasts; NProg, neuronal
progenitor; Prog, progenitor medial floorplate (FPM), lateral floorplate (FPL), midline (M), basal plate (BP); Rgl1-3, radial glia-like cells; Mgl, microglia; Endo,
endothelial cells; Peric, pericytes; Epend, ependymal; OPC, oligodendrocyte precursor cells.
(D) Molecularly defined cell types of the mouse embryonic midbrain. Cell types are named as above (C).
(E) Human ventral midbrain single-cell transcriptomes visualized with t-Distributed stochastic neighbor embedding (t-SNE), colored by the clusters defined in (C).
Contours are drawn to contain at least 80% of the cells belonging to the category.
(F) Mouse ventral midbrain single-cell transcriptomes visualized with t-SNE, colored by the clusters defined in (D). Contours are drawn to contain at least 80% of
the cells belonging to the category.RESULTS AND DISCUSSION
Development of the Mouse and Human Ventral Midbrain
We performed unbiased single-cell RNA-seq at different devel-
opmental stages (Figures 1A, 1B, and S1A–S1G) covering
dopaminergic progenitor specification, neurogenesis, and differ-entiation in human (Almqvist et al., 1996; Freeman et al., 1991). A
total of 1,977 ventral midbrain cells were analyzed from ten hu-
man embryos (6–11 weeks; Table S1). In addition, we analyzed
1,907 single-cell transcriptomes from the mouse ventral
midbrain, using a total of 271 embryos from 22 pooled litters
covering six developmental time points (E11.5–E18.5; TableCell 167, 566–580, October 6, 2016 567
S1). 245 postnatal murine cells (77 Th+ neurons and 168 puta-
tive dopaminergic neurons sorted from Slc6a3-Cre/tdTomato
mice by FACS [fluorescence-activated cell sorting]) were also
examined.
Both mouse and human datasets were then analyzed in paral-
lel using the same algorithms. We clustered the data using Back-
SPIN (Zeisel et al., 2015), resulting in a total of 25 (human) and 26
(mouse) clusters (Figures 1C–1F, S1H, and S1I). Similar results
were obtained using affinity propagation (Figures S1L and
S1M). Each cluster was supported by at least five independent
litters (mouse) and four fetuses (human), and the number of
animals contributing to each cluster matched expectations of
random sampling (Figures S1J and S1K).
We combined RNA-seqmarkers, in situ hybridization, the time
of sampling, and prior knowledge to name every cell transcrip-
tional state that we found. Below, we use shorthand labels to
indicate these clusters, prefixed to indicate the species (e.g.,
mRgl1 versus hRgl1 [mouse versus human radial glia-like cells
type 1]). Using the embryo age as a variable, we tracked the
appearance and disappearance of cell types during ventral
midbrain development (Figures 1C and 1D).
The quantitative nature of the data (Figures S1A–S1G) allowed
us to estimate the absolute level of expression for each gene in
every cell type, in units of detected mRNA molecules per cell
(with a detection efficiency of 20%; Zeisel et al., 2015), and
to estimate the underlying cell-type-specific expression levels
using a Bayesian generalized linear model (STAR Methods). A
selection of genes that can be used to identify cell types is shown
in Figures S2 (human) and S3 (mouse), and cell-type-specific
transcriptional factor combinations for both human and mouse
cells are shown in Figures S4A and S4B, respectively. The full
set of differentially expressed genes is given in Table S2.
Timing andCell Proliferation Differ inMouse and Human
Development
Although embryos are of similar size at very early time points, the
human brain outgrows the mouse by 1,000-fold (Herculano-
Houzel, 2009). While most of the difference occurs in the fore-
brain, the human midbrain is also significantly larger than the
murine (i.e., 300,000 hDA neurons versus 30,000 mDA [Nelson
et al., 1996]). The difference is partly achieved by a longer gesta-
tion. However, a 10-fold increase in neuronal numbers would
require only four extra cell divisions; thus, the timing and dy-
namics of human versus mouse midbrain development cannot
be a simple matter of linear scaling.
In order to shed light on this process, we aligned human cell
types with their mouse counterparts using a pairwise correlation
of homologous genes (Figure 2A). Non-neural cell types (Endo
[endothelial]; Peric [pericytes]; Mgl [microglia]) were mutual
best matches, as were some of the mature neuronal cell types
(OMTN, [oculomotor and trochlear nucleus]; RN [red nucleus];
DA0-2 [dopaminergic 0-2]; Sert [serotonergic]). Several neuro-
blast types were also mutual best matches, including medial
neuroblasts (NbM), the precursors of dopaminergic neurons.
However, two immature dopaminergic cell types in the mouse
(mNbDA and mDA0) corresponded to only a single type in the
human (hDA0). In addition, radial glia-like cells Rgl2 and Rgl3
matched, whereas earlier mRgl1 andmouse neuronal progenitor568 Cell 167, 566–580, October 6, 2016(mNProg) had a more complex relationship with human progen-
itor cell types due to changes over time, as discussed below.
Plotting the time of appearance of each cell type (relative to a
previously published multispecies model based on key neurode-
velopmental events, Workman et al., 2013; STAR Methods), we
found that several neuronal types appeared at homologous
time points (Figure 2B). However, Peric and Endo, as well as
NbM and mediolateral neuroblasts (NbML), were found later in
the human, whereas GABAergic neuroblasts, DA1, OMTN, and
RN appeared early. Thus, specific intermediate cell types follow
different timelines from one species to another, in which for
instance, the transition from NbML to DA1 was relatively shorter
in human than in mouse.
We then examined the proportion of VZ cells, intermediate
cells in the dopaminergic lineage (NbM, NbDA and DA0), and
dopaminergic neurons (DA1 and DA2) in the two species during
development. We found a relative depletion of human neuro-
blasts (Figures 2C–2E) compared to the mouse. We hypothe-
sized that these differences were the result of human progenitors
dividing less frequently (although the total number of cell divi-
sions would be larger; Pollen et al., 2015), such that at any given
time point there would be fewer cells differentiating from progen-
itor cells to neurons.We computed a proliferation index based on
an unsupervised selection of cell-cycle-associated genes (STAR
Methods), classifying each cell as proliferative or not. In agree-
ment with our hypothesis, human VZ cells in the dopaminergic
lineage were only about half as proliferative as those of the
mouse (Figure 2C). Thus, the larger human ventral midbrain is
generated by less proliferative progenitors active over a longer
period of time.
Finally, we examined the extent to which the expression levels
of cell-type-specific genes are conserved between species, ex-
ploiting the fact that we had measured absolute mRNAmolecule
counts. We collected all homologous genes that were enriched
(independently in each species) in homologous cell types and
plotted their expression (Figures 2F and 2G). As a control, we
examined the maximal expression of all genes in the cell types.
Cell-type-specific, absolute gene expression levels were strik-
ingly conserved (Figure S6H), with an overall correlation coeffi-
cient of r2 = 0.5, which was significantly greater than the correla-
tion of non-cell-type-specific gene expression (r2 = 0.28, p < 23
1012). Hence, genes expressed in homologous cell types tend
to have retained their specific absolute expression levels, sug-
gesting that they perform a similar function. In contrast, genes
that have diverged such that they are no longer expressed in ho-
mologous cell types have also diverged in expression levels,
suggesting that they have been co-opted to perform distinct
functions or that they now perform the same function in distinct
environments requiring different expression levels.
A Diversity of Radial Glial Cell Types
We found five distinct cell types in the mouse VZ: a progenitor
(mNProg), three distinct radial glia-like cell types (mRgl1–3),
and ependymal cells (mEpend), which all shared the expression
of the transcription factors Sox2, Sox9, Sox21, and Rfx4 (Figures
S3 and S4B). In human, the diversity was even greater, with
eleven cell types: five early progenitor cells, five radial glia-
like cell types (hRgl1, hRgl2a, hRgl2b, hRgl2c, hRgl3), and
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Figure 2. Human and Mouse Cell Type Homologies
(A) Cross species similarity of all cell types in human (horizontally) and mouse (vertically). Vertical lines indicate highest correlation of human cell type to mouse.
Horizontal lines indicate highest correlation of mouse cell type to human. Crosses are formed for cell types that aremutual best matches, indicated by blue text on
cell type labels.
(B) Time-course comparison of human versus mouse development, showing for each cell type the time point when half of all cells of that type have appeared.
Solid curve shows the translation of mouse to human developmental time, based on the timing of key neurodevelopmental events. Error bars show 95%
confidence intervals.
(C) Number of cells representing stages of the dopaminergic lineage in the mouse and human. Cells were assigned to VZ (mRgl1-3, mNProg, and mEpend),
dopaminergic neuroblasts (mNbM, mNbDA), and dopaminergic neurons (mDA0-2). Putatively dividing cells, as determined by the proliferation index, are shown
in orange.
(D) Schematic of early human and mouse cell-type compartments (not to scale).
(legend continued on next page)
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oligodendrocyte precursor cells (OPCs). All of these cells shared
the expression of SOX2, while RFX4 was not observed in
hNProg, hRgl2c, and hOPC (Figures S2 and S4A). All hRgl and
hOPCs expressed SOX9 and HES5, and each of them was
also unambiguously identified by the expression of individual
or combinations of transcription factors (Figure S4A). Compari-
son between the two species revealed the exclusive expression
of Sox2 in all VZ cell types and that all radial glia-like cells share
Fabp7, coding for a fatty acid binding protein induced by Notch
signaling (Anthony et al., 2005). However, differences in tran-
scription factor expression such as Sox9 and Sall2 were also
detected (Figures S4A and S4B).
To examine whether mRgl1–3 cells occupy different com-
partments of the VZ, we performed multiplexed single-mole-
cule RNA fluorescence in situ hybridization (RNA smFISH) (Lu-
beck et al., 2014; Lyubimova et al., 2013) using eight genes
either shared or specific to different cell types (Figures 3A–
3C; Table S3). We stained all eight genes sequentially on the
same sections and examined embryos at three developmental
stages (E11.5, 13.5, and 15.5) and three anteroposterior levels
(Figures 3A, 3D, and S5). The transcription factor Rfx4, shared
by all five mouse VZ cell types, confirmed the localization of
these cells in the VZ (Figure 3F). mNProg cells, identified by
Msx2 expression, were only present in the floor plate, span-
ning the entire VZ (Figures 3D, 3E, 3H, and S5). In contrast,
mRgl2 cells, identified by the expression of Ednrb and
Slc6a11, the GABA reuptake transporter, were confined to
the basal plate VZ from E11.5 to E15.5 (Figures 3D, 3E, 3G,
3J, 3K, 3P, and S5). mRgl1 cells (Rfx4+/Ednrb+/Slc6a11–/
Cd36–) were observed in both the floor and basal plates (Fig-
ures 3D, 3I, 3L, and S5), while Cd36+ mRgl3 were found in the
VZ of the floor plate at E15.5, appearing alongside Foxj1+ mE-
pend cells in this region (Figures 3D, 3M, 3O, 3P, and S5).
Combined, these findings demonstrate a previously unsus-
pected spatial and temporal dynamic arrangement of multiple
molecularly diverse radial glia-like cell types.
While mNProg and mEpend cells were confined to the VZ, the
somata of mRgl1–3 were found not only in the VZ, but also
emerging from the VZ and in the adjacent intermediate and mar-
ginal zones, fromE13.5 to E15.5 (Figures 3D, 3K, 3L, 3N, and S5),
showing that they migrate away from the VZ as it has been
described for human cortical outer radial glia (Taverna et al.,
2014). Since mRgl2 shared with adult astrocytes the expression
of markers such as Slc6a11, TncI, and Aldoc (Cahoy et al., 2008;
Hatada et al., 2008; Karus et al., 2011) and radial glia cells can
generate astrocytes and oligodendrocytes (Kriegstein and Al-
varez-Buylla, 2009; Spassky et al., 2005), we suggest that cells
migrating away from the VZ may be initiating gliogenesis.
Notably, our analysis of the human midbrain also identified
hOPC, as well as a radial glia-like cell type with expression of
some OPC markers (hRgl2c, expressing OLIG2 and ETV5; Fig-
ures S2 and S4A). Examination of E13.5 mouse tissue (Figures(E) Schematic of late human and mouse cell-type compartments (not to scale).
(F) Human genes specifically expressed in mutually best-matching cell types in
bability >99.8%. Right axis shows absolute molecule counts.
(G) Same genes as in (F) but for the corresponding mouse cell types, shown as vio
axis shows absolute molecular counts. Note that the vertical scales are the sam
570 Cell 167, 566–580, October 6, 20163D, 3K, and S5) similarly revealed the presence of cells in the
basal plate with radial glia markers, Ednrb and Rfx4, as well as
the OPC marker Sox10, but little or no Pdgfra (also an OPC
marker). Two days later, in the same position, we observed
Pdgfra+/Sox10+/Ednrb+ OPCs (Figures 3D, 3N, and S5). These
findings suggest that OPCs are likely generated from basal plate
radial glia, through a subventricular radial glia-like cell type
(Rgl2c) that expresses Sox10, but not yet Pdgfra, as it emerges
from the VZ. Our results thus identify Rgl2c as a subventricular
radial glia-like cell type and as a cell type in the oligodendrocyte
lineage, linking VZ Rgl with OPCs.
Neuronal Progenitors, Neuroblasts, and Non-
Dopaminergic Neurons
The diversity of neurons in the ventral midbrain is generated as a
result of patterning events that define spatial domains of differ-
entiation. While only one neuronal progenitor (mNProg) was
found in the mouse VZ, five different progenitors were identified
in human (hNProg; hProgM [midline progenitor]; hProgFPM
[medial floorplate progenitor]; hProgFPL [lateral floorplate pro-
genitor]; hProgBP [basal plate progenitor]). All human progeni-
tors expressed HMGA1 and HMGB2 and shared with hRgl1
the expression of OTX2 (which distinguishes the forebrain and
midbrain from the hindbrain [Acampora et al., 1995]). The mouse
midline marker CORIN1 (Ono et al., 2007) was expressed
together with TOX, a transcriptional regulator of Sox2 (Artegiani
et al., 2015), in hProgM. Floorplate progenitors were identified by
the expression of LMX1A, a transcription factor that specifies
dopaminergic neurons (Andersson et al., 2006) and labels the
human floorplate (Hebsgaard et al., 2009). High levels of the
morphogen WNT1, expressed in the lateral aspect of the floor-
plate at E10.5 (Prakash et al., 2006), identified hProgFPL and
hProgFPM (low WNT1 levels; Figure S2). Laterally, hProgBP
were found to express FOXA2 and DMBX1, but not WNT1 or
LMX1A (Figures S2 and S4A). These four progenitors also ex-
pressed CNPY1, a positive regulator of FGF signaling in the
midbrain-hindbrain region (Hirate and Okamoto, 2006). Lastly,
hNProg expressed pro-neurogenic genes such as NEUROG1
and shared with the hNbM the expression of NEUROD1,
NEUROD4, NEUROG2, and NHLH1 (Figure S4A), indicating an
active role in neurogenesis. These findings show thatmolecularly
defined human progenitor cell types correspond to previously
defined ventral midbrain domains in mouse.
Among mouse neuroblasts, we identify eight cell types that
were very similar but with each expressing known transcription
factors that defined their spatial position in the anterior/posterior
and medial/lateral axes as well as markers that are maintained
in the neuronal types they give rise to (Figures 4A–4C). For
instance, mNbM expressed a nuclear receptor required for
dopaminergic neuron development,Nr4a2 (known asNurr1; Zet-
terstro¨m et al., 1997). Mediolateral neuroblasts type 1 (mNbML1)
expressed Cartpt, as well as Nkx6-2, which is found in the(A), shown as violin plots. Grey, enriched over baseline with posterior pro-
lin plots. Grey, enriched over baseline with posterior probability >99.8%. Right
e as in (F).
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Figure 3. Diversity of Ventricular Zone Cell Types
Single-molecule RNA FISH (RNA smFISH) was performed at three anteroposterior positions and three developmental time points, eachwith eight genes detected
in the same single tissue section by sequential hybridizations. For clarity, the panels of this figure show subsets ofmarkers, but all eightmarkerswere stained for in
the same single sections.
(A) Schematic of coronal sections taken in anteroposterior axis over several developmental time points, not to scale.
(B) Representative images of sequential RNA smFISH with eight probes over three cycles and corresponding composite.
(legend continued on next page)
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Figure 4. Neuroblast Patterning
(A) Mouse neuroblast populations and their markers. Grey, enriched over baseline with posterior probability >99.8%.
(B) Simplified illustration of the patterning of the ventral midbrain, based on transcriptionally defined domains. Left, coronal view; right, sagittal views at the
indicated levels (L1 and L2).
(C) In situ hybridization (image data from Allen Institute for Brain Science: Allen Developing Mouse Brain Atlas) for key domain-specific transcription factors and
markers. Dashed lines indicate the approximate extent of the ventral region used in our dissections (scale bar, 200 mm).intermediate zone domain where OMTN and RN neurons appear
(Prakash et al., 2009), in themidbrain domain m6 (Nakatani et al.,
2007). We also found mediolateral neuroblasts capable of giving
rise to GABAergic neurons (Achim et al., 2013), such as Tal2+
mNbML2 in m5 and m3-1, and Gata3+ mNbML5 in m5-m3.(C) The expression of genes selected for RNA smFISH in mouse and human VZ ce
distribution for the expressed number of mRNA molecules per cell type. Grey,
absolute molecule counts.
(D) Diagram showing the spatiotemporal location of cells discovered by RNA s
Representative images are shown in Figure S5.
(E) RNA smFISH showing the distribution of Msx2, Ednrb, and Slc6a11 in the E1
(F) Signal for Rfx4 on the same section as (E), shown separately for clarity.
(G) Inset as indicated in (E).
(H) Inset as indicated in (E).
(I) Inset as indicated in (E).
(J) RNA smFISH showing the distribution of Rfx4, Msx2, and Slc6a11 in the E13.
(K) Inset as indicated in (J) with additional markers Pdgfra, Sox10, and Ednrb. *,
(L) Inset as indicated in (J) showing markers in (K) in addition of Cd36.
(M) RNA smFISH showing the distribution of Rfx4, Cd36, and Slc6a11 in the E15
(N) Inset as indicated in (M) with additional markers Pdgfra, Sox10, Foxj1, Ms
parenchyma.
(O) Inset as indicated in (M) with additional markers Pdgfra, Sox10, and Ednrb in
(P) RNA smFISH showing Foxj1, Msx2, Slc6a11, and Ednrb. Arrowheads indicate
572 Cell 167, 566–580, October 6, 2016The progressive changes in gene expression profiles from
neuroblasts to mature neurons led us to think that neuronal dif-
ferentiation may mainly involve gain of gene expression. We
tested this idea in mOMTNs, which were present already at
early time points (identified by fundamental transcriptionll types shown as violin plots. The violin plots represent the posterior probability
enriched over baseline with posterior probability >99.8%. Right axis shows
mFISH in the sections shown in (A). VZ, ventricular zone; PA, parenchyma.
1.5 ventral midbrain.
5 ventral midbrain.
putative mRgl2 cell; arrow, putative intermediate between Rgl2 and OPC.
.5 ventral midbrain.
x2, and Ednrb. *, putative mRgl2 cell; arrow, putative mOPC located in the
the VZ.
putative ependymal cells in VZ.
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Figure 5. Comparison of Mouse and Human Dopaminergic Neuronal Development
(A) WNT1 compartments marking lateral population of the floor plate in human and mouse tissue (scale bar, 100 mm).
(B) Bar plot of cell types of the human and mouse dopaminergic lineage, showing the expression of key genes. Bars show average mRNA expression, scaled to
the absolute molecule counts indicated on the right axis. Error bars show SEM.
(C) Validation of mNbM by in situ hybridization for Igfbpl1 and Nhlh1 (scale bar, 50 mm).
(D) Neuroblasts in human and mouse ventral midbrain (scale bar, 100 mm; magnification, 20 mm).
(E) Selected genes showing similar (left) or distinct (right) expression in mouse and human ventral midbrain. Blue, expressed above baseline in mouse (>99.8%
posterior probability); green, expressed above baseline in human (>99.8% posterior probability); gray, not expressed above baseline.
(F) Validation of LMO3 expression by immunohistochemistry in a subset of TH+ neurons in the E18.5 mouse ventral midbrain (scale bar left, 100 mm; right, 20 mm).
(G) Validation of BNC2 expression by immunohistochemistry in TH+ neurons in the E18.5 mouse ventral midbrain (scale bar left, 100 mm; right, 20 mm).factors such as Isl1, Lhx4, Phox2a, Phox2b, and Tbx20; Fig-
ure S3). A pseudotime analysis over developmental time (Fig-
ure S6A) showed that late motorneurons acquired the expres-
sion of Pvalb (Figure S6B), as well as genes such as Gria1,
Hmgn3, Esrrb, Trank1, and Ret. In fact, 121 genes were signif-
icantly upregulated, but not a single gene was downregulated
(STAR Methods). Similarly, mSert and hSert were characterized
by highly specific induction of the key genes necessary for
serotonergic synaptic function (Deneris and Wyler, 2012) (Fig-
ures S6C–S6E). Thus, after the acquisition of a basic neuronalidentity, maturation appears to mainly involve the addition of
genes with cell-type-specific functions.
Diversity inMouse andHuman Embryonic Dopaminergic
Neuron Development
Focusing on the dopaminergic lineage revealed both similarities
and differences between species. Similarities included that floor-
plate progenitors found in human were also present in mouse, at
E10.5, as assessed by the presence of Wnt1 in lateral floorplate
progenitors (Figure 5A; Prakash et al., 2006). The first postmitoticCell 167, 566–580, October 6, 2016 573
cell in the dopaminergic lineage in bothmouse and human, NbM,
expressed not onlyNr4a2, but also Igfbpl1 and transcription fac-
tors such as Neurod1, Neurod2, Klf12, and Nhlh1 (Figures 5B
and 5C). Notably, NbM and NProg in both species also shared
the expression of Neurog2, a proneural gene required for dopa-
minergic neurogenesis (Kele et al., 2006).
We also found three distinct types of embryonic dopaminergic
neurons in both mouse and human (Figure 5B): (1) a very imma-
ture DA0, which expressed tyrosine hydroxylase (Th), the rate-
limiting enzyme in the synthesis of dopamine, in addition to the
factors above; (2) DA1 neurons, which additionally expressed
the dopamine transporter, Slc6a3; and (3) DA2 neurons, distin-
guished by the specific addition of Aldh1a1 and the transcrip-
tional co-regulator Lmo3, a LIM domain only protein that
interacts with basic-loop-helix proteins to regulate neurogenesis
and has been involved in the specification of hippocampal neu-
rons (Bao et al., 2000; Hinks et al., 1997). In addition, we identi-
fied and validated two genes conserved in mouse and human
dopaminergic neurons: Bnc2, expressed in all dopaminergic
neurons, and Lmo3, expressed in subset a of TH+ cells (Figures
5E–5G).
However, a number of differences in mouse and human dopa-
minergic neuron development were also identified. First, key
transcription factors such asMsx1 and Lmx1a, the latter required
for the specification of dopaminergic neurons (Andersson et al.,
2006), did not appear in the same cell types: mNProg (Figure S3)
versus hRgl1 (Figure S2). Second, an intermediate neuroblast,
mNbDA (expressing Pbx1, but not Th) was found in mouse, but
not in human (Figure 5D). Third, Ebf2, a transcription factor
regulating different aspects of dopaminergic neuron develop-
ment (Yang et al., 2015; Yin et al., 2009), was found in the two
mouse neuroblasts (mNbM and mNbDA), but in human, it ap-
peared later, in immature dopaminergic neurons (hDA0). The
same was true for transcription factors expressed in mNbDA,
such as Pbx1 and Pitx3, both required for dopaminergic devel-
opment (Nunes et al., 2003; Villaescusa et al., 2016), which
were only found in hDA0 (Figures 5B and 5D). Fourth, a detailed
analysis of gene expression in human and mouse dopaminergic
neuroblasts and neurons (Figure 5E) revealed notable species
differences in gene expression. For instance, Cck, Grin2b, and
Homer2were not detected in human cells, and specific ion chan-
nels present in human, such as KCNJ6, were not detected in
rodent (Figure 5E).
Adult Ventral Midbrain Dopaminergic Neuron Subtypes
Emerge Postnatally
Previous work by single-cell qPCR on FACS-sorted SLC6A3+
cells (Poulin et al., 2014) identified five types of dopaminergic
neurons postnatally. We confirmed this finding in a separate
single-cell RNA-seq analysis of adult mouse dopaminergic
neurons (Figures 6A and 6B). The presence of the pan-dopami-
nergic marker, AJAP1, in TH+ cells was validated by immuno-
histochemistry (Figure S6G). One cell type mapped to the
SNc (mDA-SNC) and the rest mainly to distinct regions of the
VTA (mDA-VTA1, 2, and 4) and the periaqueductal gray
(mDA-VTA3) (Figures 6C–6G and S6F). We validated these
adult dopaminergic neuron populations and determined
their positions using the Allen Mouse Brain Atlas (Figure S6F)574 Cell 167, 566–580, October 6, 2016and by immunohistochemistry with multiple antibodies (Figures
6C–6G).
The presence of five dopaminergic cell types in the adult, and
only two in the embryo, led us to examine the postnatal matura-
tion of this lineage. We noted that some genes expressed in
embryonic mDA2 neurons at E18.5, such as Aldh1a1, Sox6,
and Calb1Low, were later found in mDA-SNC, mDA-VTA1, and
mDA-VTA2 neurons, suggesting that mDA2 neurons could
be a common ancestor. Immunohistochemical analysis of
ALDH1A1 and SOX6 during postnatal development revealed
the presence of distinct subpopulations already at P0 (Figure 6H),
suggesting that mDA2 neurons were already then maturing
into DA-SNC. However, the shared VTA marker CALB1 was
only detected at P7 (Figures 6I and 6J), indicating that their
maturation into proper DA-VTA cells occurs subsequently. At
this stage, TH, CALB1, ALDH1A1, and SOX6 allowed us to
distinguish VTA1, VTA2, and SNc cells from other VTA cells (Fig-
ure 6J). The first VIP+/CALB1+ cells were also detected at P7
(Figure 6K), indicating that further VTA subdivisions, such as
DA-VTA3, also emerge at this point. Combined, our findings
show that adult dopaminergic subtypes emerge postnatally
as a result of environmental cues rather than early patterning
events.
Stem-Cell-Derived In Vitro Dopaminergic Neurons
Cell replacement therapy is one of the most promising future
treatments for Parkinson’s disease. Transplantation of human
fetal midbrain tissue containing dopaminergic neurons has pro-
vided proof of principle for this therapeutic approach (Barker
et al., 2015). More recently, by providing some of the key devel-
opmental signals that control midbrain dopaminergic neuron
development (Arenas et al., 2015), it has become possible to
generate human pluripotent stem cell (hPSC)-derived dopami-
nergic neurons, capable of inducing behavioral recovery in ani-
mal models of Parkinson’s disease (Kirkeby et al., 2012; Kriks
et al., 2011). However, the molecular composition of hPSC-
derived preparations at a single-cell level is completely un-
known, and as the field is moving closer to clinical trials (Barker
et al., 2015), it will be important to determine whether the
cell types present in hPSC-derived cell preparations actually
resemble their in vivo counterparts.
We used our comprehensive human reference dataset to
assess the composition of such stem cell preparations at
different stages of differentiation, as well as the fidelity of
in vitro derived dopaminergic neurons as compared with those
found in vivo.
Human embryonic stem cells (hESCs) and human induced
pluripotent stem cells (hiPSCs) were differentiated using the pro-
tocol by Kriks et al. (2011) (Figure S7A). We first analyzed the
hESC (H9 and HS401 lines) cultures using classical methods
such as qPCR (Table S4) and immunohistochemistry. ESC
markers NANOG and POU5F1 expression disappeared by day
12. Examining genes required for dopaminergic neuron differen-
tiation, we found that FOXA2 peaked at day 19, LMX1A progres-
sively increased from day 12 to 35, and NR4A2 as well as TH
increased between day 19 and 35 (Figures 7A, S7B, and S7C).
Immunohistochemistry revealed that by day 47 most hiPSC-
derived cells were positive for neurofilament (TUJ1; a marker of
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Figure 6. Diversity of Adult Dopaminergic Neurons
(A) Expression of selected genes across five adult dopaminergic cell types. Colors as in (5E). *, indicates selected genes for validation in (C–K). #, indicates genes
selected for in situ validation from Allen Mouse Brain Atlas found in Figure S6F.
(B) Projected schematic of five distinct dopaminergic populations in adult ventral midbrain.
(C) Anterior to posterior representation of dopaminergic neuron populations at P21. Detection of CALB1, ALDH1A1, and TH. Green dots, TH+/ALDH1A1+/
CALB1; Yellow dots, TH+/ALDH1A1+/CALB1+; Red/Pink (high/low expression) dots, CALB1+/TH+/ALDH1A1; White dots, TH+. (scale bar, 200 mm; insets,
20 mm).
(D) Validation of dopaminergic neurons at P21. Open arrow, SOX6+/CALB1 (SNC); solid white arrow, SOX6+/CALB1+ (VTA1); solid red arrow, SOX6/CALB1+
(VTA2-4) (scale bar left, 200 mm; right, 20 mm).
(E) Validation of dopaminergic neurons at P21. Open arrow, SOX6+/ALDH1A1+ (SNC); solid white arrow, SOX6/ALDH1A1 (VTA3/4); solid red arrow, SOX6/
ALDH1A1+ (VTA2) (scale bar left, 200 mm; right, 20 mm).
(F) Validation of dopaminergic neurons at P21 in posterior section. Solid white arrow VIP+/CALB1+ (VTA3) (scale bar left, 200 mm; right, 20 mm).
(G) Validation of dopaminergic neurons at P21. Open arrow, FOXA2/CALB1+ (VTA2/4); solid white arrow, FOXA2+/CALB1+ (VTA1/3) (scale bar left, 200 mm; right,
20 mm).
(H) SOX6+/ALDH1A1+ visible at P0. Insets: open arrow, SOX6+/ALDH1A1 (putative VTA1); solid white arrow, SOX6+/ALDH1A1+ (SNC) (scale bar, 20 mm).
(I) Absence of CALB1+ in TH+/ALDH1A1 cells at P0 (scale bar, 20 mm).
(J) CALB1+ (open arrow) and CALB1+/ALDH1A1+ (solid arrow, VTA2) visible at P7 (scale bar, 200 mm; insets, 20 mm).
(K) VIP+/CALB1+ (solid arrow, VTA3) visible at midline at the posterior level of P7 (scale bar, 20 mm).mature neurons), and their processes were much longer at day
63. At day 47, most cells were positive for both FOXA2 and
LMX1A, with 85% of the cells in the culture being FOXA2+ and21% TH+ (Figure 7B). In addition, TH+ cells were NR4A2+,
PBX1+, and some expressed PITX3+ (Figure S7D), indicating
that they differentiated along the dopaminergic lineage.Cell 167, 566–580, October 6, 2016 575
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Figure 7. Single-Cell Analysis of Differentiated In Vitro Human ESC and iPSC Cultures and Prototype-Based Scoring
(A) Expression of marker genes during the differentiation protocol measured by qPCR (solid lines) or inferred by pooling of single-cell RNA-seq data per time point
(dashed lines). Red, HS401 cells; blue, H9 cells.
(B) Immunostaining of hiPSC cultures (scale bar, 50 mm).
(C) hESC-derived cell types compared with in vivo cell types. Heatmap shows correlation based on genes that show specific expression in any in vivo cell type.
Pie chart (right) shows relative contribution of each cell line to each cluster. Dot plot shows distribution of cells at different time points.
(D) Schematic of the inference of cell identity using prototype scoring. A machine learning model was trained on in vivo cell types (left) resulting in a reusable
scoring function. Stem cells were then scored and evaluated individually, without the need for clustering. Typical visualization outputs of the machine learning
model are shown in (G–I).
(E) Expression of selected genes of the dopaminergic lineage in human development, hESC-, and hiPSC-derived cell types.
(F) hiPSC-derived cell types compared with in vivo cell types. Heatmap shows correlation based on all genes that show specific expression in any in vivo cell type.
Bars (right) show relative abundances at 47 and 63 days in vitro.
(legend continued on next page)
576 Cell 167, 566–580, October 6, 2016
Single-cell RNA-seq was performed on cells obtained from
hESCs (H9 and HS401 lines) at days 0, 12, 18, and 35, as well
as hiPSCs at days 47 and 63. Pooled single-cell data closely
recapitulated the bulk expression levels of the genes previously
analyzed by qPCR (Figures 7A and S7B), confirming that no ma-
jor cell type was lost in the single-cell analysis of these cultures.
Clustering revealed the presence of 14 hESC-derived (Figures
7C and S7F) and 13 distinct hiPSC-derived cell types (Figures
7F and S7E), which resembled some of the 25 human neural
cell types present in the human fetal midbrain tissue. hESC-
derived cultures generated a range of poorly defined radial glia-
like cells and progenitors that resembled those in the floorplate
and basal plate (Figures 7C and S7G). hESC cultures also gener-
ated four types of neuroblasts from day 12 to 35, resembling
hNbM, hNbML1, and hNbGaba. hiPSCs, differentiated for 47
and 63 days, gave rise to more mature cells, including two
radial glia-like cell types and three progenitors (Figure 7F). hiPSCs
also generated two types of neuroblasts, two motor-neuron-like
cell types as well as one well-defined red-nucleus-like neuron
and three hiPSC-derived dopaminergic cell types (iDAa-c) with
features of human fetal dopaminergic neurons (hDA0-2). The
most mature dopaminergic cell type (iDAc) expressed key genes
such as NR4A2, KLHL1, PBX1, SLC18A2, TH, DDC, GFRA1, or
EN1 (Figure 7E). We conclude that these preparations contain a
cell type diversity much greater than previously known, including
TH+ cells at a stage of differentiation similar to the tissue currently
used for cell transplantation in Parkinson’s disease.
To assess the quality of the in vitro differentiated cells, we
developed a machine-learning tool that compares the transcrip-
tomes of each in vitro cell to the cell types found in vivo (Figures
7D, S7H, S7I, and S7L; STAR Methods). This approach allows
visualizing each individual cell based on the probability of being
each of the prototypical cell types (Figures 7G and S7J). While
endogenous midbrain cells showed distinct, unambiguous iden-
tities (Figures S7J and S7K), hPSC-derived cells showed more
intermediate forms (Figure 7G). However, a clear trajectory
was observed over time from pluripotent state (day 0), through
progenitors (day 12 and 18), medial and mediolateral neuro-
blasts (day 18 and 35), and finally converging on dopaminergic
cells at days 47 and 63. Thus, stem cells under these culture con-
ditions recapitulated key stages of in vivo ventral midbrain
development.
Comparing the fifteen highest-quality progenitor-like (ProgFP)
and dopaminergic-like neurons to their in vivo counterparts (Fig-
ure 7H) revealed accurate expression of key developmentally
regulated genes. For example, both embryonic and in vitro dopa-
minergic neurons expressed NR4A2, PBX1, EN1, TH, and DDC,
which were not found in progenitors. Similarly, both in vitro and
in vivo progenitors expressed VIM, HES1, SLIT2, and RFX4,
which were not found in mature neurons. However, the in vitro
cells differed from the in vivo prototypes in global expression(G) Wheel plot showing the prototype scores for hESCs and hiPSCs. Dots repre
relative score of that prototype. Colors indicate time point of differentiation (red,
(H) Heatmap showing gene expression of top-scoring dopaminergic (left) and floor
subpanel) and in vitro (right in each subpanel) cells. Genes shown have the top
respectively.
(I) Histograms of prototype scores for human dopaminergic clusters and hiPSC-profiles and scores (Figures 7I and S7M) indicating that further
improvement of differentiation protocols is possible.
In sum, our analysis identifies not only genes and cell types in
mouse and human ventral midbrain development, but also pro-
vides tools toevaluategeneexpression instem-cell-deriveddopa-
minergic preparations, determine their quality, and guide future
improvements in Parkinson’s disease cell replacement therapy.
We propose this approach as a preferred strategy for assessing
the quality of stem cell preparations for clinical applications.STAR+METHODS
Detailed methods are provided in the online version of this paper
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DAPI Sigma-Aldrich Cat#D9542
TO-PRO-3 Iodide Thermo Fisher Scientific Cat#T3605
Donkey anti-Rabbit Alexa Fluor 350 secondary Thermo Fisher Scientific Cat#A10039
RRID: AB_11180201
Donkey anti-Rabbit Alexa Fluor 488 secondary Thermo Fisher Scientific Cat#A21206
RRID: AB_141708
Donkey anti-Rabbit Alexa Fluor 555 secondary Thermo Fisher Scientific Cat#A31572
RRID: AB_10562716
Donkey anti-mouse Alexa Fluor 488 secondary Thermo Fisher Scientific Cat#A21202
RRID: AB_141607
Donkey anti-mouse Alexa Fluor 555 secondary Thermo Fisher Scientific Cat#A31570
RRID: AB_2313501
Donkey anti-mouse Alexa Fluor 647 secondary Thermo Fisher Scientific Cat#A31571
RRID: AB_2313501
Chicken anti-goat Alexa Fluor 488 secondary Thermo Fisher Scientific Cat#A21467
RRID: AB_10055703
Donkey anti-goat Alexa Fluor 555 secondary Thermo Fisher Scientific Cat#A21432
RRID: AB_10053826
Donkey anti-sheep Alexa Fluor 488 secondary Thermo Fisher Scientific Cat#A11015
RRID: AB_10561557
Donkey anti-sheep Alexa Fluor 647 secondary Thermo Fisher Scientific Cat#A21448
RRID: AB_10374882
Goat anti-guinea pig Alexa Fluor 488 secondary Thermo Fisher Scientific Cat#A11073
RRID: AB_2307359
Rabbit polyclonal anti-VIP Abcam
Gift: Ulrika Marklund
Cat#ab43841; RRID: AB_778831
Guinea pig anti-SOX6 Gift: Jens Hjerling-Leffler N/A
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
Human recombinant laminin-521 BioLamina Cat#LN521
Human recombinant laminin-111 BioLamina Cat#LN111
Laminin mouse protein Thermo Fisher Scientific Cat#23017015
Laminin Sigma-Aldrich Cat#L2020
NutriStem hPSC XF Medium Biological Industries Cat#05-100-1A
Hibernate-E Medium Thermo Fisher Scientific Cat#A1247601
N-2 Supplement Thermo Fisher Scientific Cat#17502048
B-27 Supplement Thermo Fisher Scientific Cat#17504044
Neurobasal Medium Thermo Fisher Scientific Cat#21103049
Glasgow’s MEM (GMEM) Thermo Fisher Scientific Cat#11710035
KnockOut Serum Replacement Thermo Fisher Scientific Cat#10828028
MEM non-essential amino acids Thermo Fisher Scientific Cat#11140-050
Fibronectin Sigma-Aldrich Cat#F0895
TrypLE Select Enzyme Thermo Fisher Scientific Cat#12563011
Poly-L-ornithine solution Sigma-Aldrich Cat#P4957
CHIR99021 Sigma-Aldrich Cat#SML1046
Ascorbic acid Sigma-Aldrich Cat#A4544
dbcAMP Sigma-Aldrich Cat#D0627
Y-27632 Tocris Cat#1254
SB 431542 Tocris Cat#1614
LDN193189 Stemgent Cat#04-0074
Recombinant human SHH (C24II) R&D Systems Cat#1845-SH-100/CF
Recombinant human FGF8b R&D Systems Cat#423-F8/CF
Recombinant human BDNF R&D Systems Cat#248-BD-025/CF
Recombinant human GDNF R&D Systems Cat#212-GD-050/CF
Recombinant human TGFb3 R&D Systems Cat#243-B3
SP6 RNA polymerase Thermo Fisher Scientific Cat#EP0133
DIG RNA Labeling Mix Roche Cat#11277073910
Anti-Digoxigenin-AP, Fab fragments Roche Cat#11093274910
RRID: AB_514497
NBT/BCIP Stock Solution Roche Cat#11681451001
Critical Commercial Assays
Papain Dissociation System Worthington Biochemical Cat#LK003150
RNeasy Mini Kit QIAGEN Cat#74104
Deposited Data
Single-cell RNA-sequencing raw data files NCBI GEO GEO: GSE76381
Experimental Models: Cell Lines
Human: H9 Thomson et al., 1998 N/A
Human: HS401 Rodin et al., 2014 N/A
iCell DopaNeurons Kit Cellular Dynamics International Cat#DNC-301-030-001
Experimental Models: Organisms/Strains
Mouse: Crl:CD1(ICR) Charles River N/A
Mouse: B6.SJL-Slc6a3tm1.1(cre)Bkmn/J Jackson Laboratories RRID: IMSR_JAX:006660
Mouse: B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J Jackson Laboratories RRID: IMSR_JAX:007914
Sequence-Based Reagents
C1-P1-PCR2 Islam et al., 2014 N/A
C1-TN5-U Islam et al., 2014 N/A
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
C1-P1-T31 Islam et al., 2014 N/A
C1-P1-RNA-TSO Islam et al., 2014 N/A
Primers for single-molecule RNA FISH; Table S3 This paper N/A
Primers for qPCR; Table S4 This paper N/A
In Situ Forward Primer, Nhlh1, TGT TCA GCC ACA
AGC TGC
This paper N/A
In Situ Reverse Primer, Nhlh1, GAG ATT TAG GTG
ACA CTA TAG AGC GCT CCT CAC GAC TCA A
This paper N/A
In Situ Forward Primer, Igfbpl1, TCA CCT TGC ATG
AAC AGC TCA G
This paper N/A
In Situ Reverse Primer, Igfbpl1, GAG ATT TAGGTG
ACA CTA TAG ACT TGC CCA GGG TCA TAC AG
This paper N/A
Software and Algorithms
Cell-scoring command-line tool This paper http://github.com/linnarsson-lab/
ipynb-lamanno2016/tree/master/scoringtool
Ipython notebooks showing key steps of the
analysis
This paper http://github.com/linnarsson-lab/
ipynb-lamanno2016
BackSPIN algorithm Zeisel et al., 2015 https://github.com/linnarsson-lab/BackSPINCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to, and will be fulfilled by the Lead Contact Sten Linnarsson (sten.
linnarsson@ki.se).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Wild-type CD-1 mice were obtained from Charles River (Germany). CD-1 mice were mated overnight and noon of the day was
considered E0.5 and then shipped as pregnant females. Mice were housed in rooms with regular dark/light cycle and fed standard
rodent diet and water ad libitum. Mice were housed in groups up to four animals on saw dust bedding and straw for nest building.
For postnatal animals, the day mice were born was considered P0. A DAT1-Cre driver line (Ba¨ckman et al., 2006) was crossed with
a floxed tdTomato reporter strain (Madisen et al., 2010), resulting in a DAT1-Cre/tdTomato mouse strain expressing tdTomato in
DAT1 (dopamine transporter, Slc6a3) positive neurons. Mice were housed and tissue obtained following guidelines and permis-
sions from the local ethics committee, Stockholm Norra Djurfo¨rso¨ksetisks Na¨md (N326/12), and Swiss National and Institutional
guidelines.
Human tissue
Human fetal tissues were collected from routine termination of pregnancies at Addenbrooke’s Hospital (Cambridge) and
dissected in HIBERNATE media. Samples for single cell analysis were screened for biohazards and then shipped overnight
on ice (in HIBERNATE media) to Sweden. Ethical approval for the use of postmortem human fetal tissue was provided by the
National Research Ethics Service Committee East of England - Cambridge Central (Local Research Ethics Committee, reference
no. 96/085).
Cell lines
hiPSC-derived dopaminergic neurons (iCell DopaNeurons) were obtained from Cellular Dynamics International (lot#6003358) were
cultured following the manufacturer’s recommendations. Briefly, cells were thawed and plated on PLO and Laminin coated plates
withmedia and supplements provided bymanufacturer. Cells were cultured in a 37C, 5%CO2 incubator, andmedia was exchanged
every 2-3 days.
Human ESCs H9 (passage 46-49) (Thomson et al., 1998) and HS401 (passage 40-43) (Rodin et al., 2014) were maintained on a
recombinant human laminin-521 (BioLamina) coated dish with NutriStem hESC XF (Biological Industries). These cells were passaged
at 1:10-1:20 ratio for each passaging (Rodin et al., 2014). The cell lines were authenticated as ES cells by qPCR and immunohisto-
chemistry using a standard panel of stem cell markers and dopaminergic lineage markers.Cell 167, 566–580.e1–e10, October 6, 2016 e3
METHOD DETAILS
Tissue collection
CD-1 mice were sacrificed and embryos were dissected out of the uterine horn between the time points E11.5 and E18.5. Between
6-16 ventral midbrain tissue pieces (see Table S1) were dissected from embryonic brain in N2 culturing media (MEM/F12 media,
HEPES, N2 supplement (LifeTechnologies)) for each experiment and the entire procedure was performed on ice. Tissue was
dissected and collected into ice cold N2 media until dissociation step. For CD-1 postnatal tissue, mice were anaesthetized with iso-
flurane (Baxter) and perfused with cutting solution [87 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 26 mM NaHCO3, 75 mM Sucrose,
20mMGlucose, 0.5mMCaCl2*H2O, 7mMMgSO4*7H2O] and tissue collected at P19 to P27. Ventral midbrain (SNc and VTA) dissec-
tion was done by 300 mm thick vibratome (Leica) coronal sections and SNc/VTA cut out with scalpel. Sectioning and cutting were
completed in oxygenated (5% CO2/95%O2) cutting solution. For each experiment 2-3 mice were used (see Table S1) and 3-4 slices
per brain. Entire procedure and solutions were kept cold and oxygenated. For transgenic DAT1-Cre/tdTomato mice, P28 and P56
non-anaesthetizedmice were rapidly decapitated and their brains carefully removed and kept in ice-cold, artificial cerebrospinal fluid
for dissection and dissociation (ACSF-D) [200 mM Sucrose, 2.6 mM KCl, 10 mM MgCl2, 0.5 mM CaCl2, 26 mM NaHCO3, 1.27 mM
NaH2PO4 and 10 mM Dextrose] (equilibrated with 5% CO2/95% O2) (pH 7.3). Coronal, 400 mm thick slices were cut on a vibratome
and transferred to ice-cold ACSF-D. The SNc and VTA were subsequently dissected out with a scalpel under the visual guidance of a
fluorescent stereomicroscope.
Embryonic mouse, human, and postnatal CD-1 tissue pieces were processed similarly by dissociation using Papain Dissociation
System (Worthington) following the manufacturer’s recommendations, adjusting incubation time based on tissue piece size,
25-45 min. Briefly, after papain incubation, glass pipettes of increasingly smaller tip diameter (fire-polished) were used to dissociate
to single-cell suspension followed by a centrifugation through a BSA single step discontinuous density gradient. Then cells were
filtered with 20 mm strainer (Partec CellTrics). Cells were pelleted, resuspended, and stored in N2 media with DNaseI until they
were loaded into Fluidigm C1 chips for cell capture. DAT1-Cre/tdTomato midbrain tissue pieces were gently dissociated in 1 mL
ACSF-D solution containing 1.1 mM EDTA, 10 mM L-Cysteine and 15U papain, activated for 15-30 min at 37C. After dissociation
the cell suspension was filtered (30 mmmesh) into 1mL of ACSF-D with 0.5% BSA and damaged cells stained with 0.1% Propidium
Iodide (PI). Single cells positive for tdTomato and negative for PI were sorted on a FACS ARIA II (equipped with a 100 mm nozzle)
directly into 3 ml of ice cold ACSF-D with 0.5% BSA in the cell collection chamber of a Fluidigm C1 chip to a final concentration
100-150 cells/mL. The collected cells were processed immediately after FACS on the Fluidigm C1 System according to the C1-
STRT protocol (Zeisel et al., 2015). Briefly, C1-STRT (also called STRT-seq) is implemented on the Fluidigm C1 Single-Cell Auto
Prep System. The protocol consists of cell capture, cell wash, imaging, cell lysis, reverse transcription and full-length cDNA PCR
all performed in disposable microfluidic chips (Fluidigm C1 Single-Cell Auto Prep IFC for mRNA Seq, medium size, 10 mm –
17 mm). Following elution from the chip, the amplified cDNA is then tagmented using Tn5 transposase, purified and sequenced on
the Illumina HiSeq platform. The following sections describe each step in brief. For detailed protocols, see (Islam et al., 2014).
Single cell isolation and cDNA synthesis
14 ml of cell suspension (approx. 800 cells/ml in N2 culturing media with DNaseI) was mixed with 7 ml C1 Suspension Reagent
after filtering. Single-cells were then captured for 30 min at 4C using the ‘‘Cell Load (1772x/1773x)’’ script. Bright-field
imaging of every capturing site was performed on a Nikon TE2000E automated microscope using mManager (https://
micro-manager.org/).
Immediately after the image acquisition, the chip was returned to the Fluidigm C1 System and the protocol for Lysis, RT and PCR
were performed as previously described (Islam et al., 2014). After completion for the cDNA, the amplified cDNA was harvested with
13 ml Harvest Reagent and cDNA library quality was measured on an Agilent BioAnalyzer.
Preparation of sequencing library
The images of the capture sites were inspected and only capture site with single healthy cells were selected for library preparation.
Cell barcoding and fragmentation, was performed in a single step using Tn5 DNA transposase (‘tagmentation’) as described previ-
ously. 1 ml DynabeadsMyOne Streptavidin C1 beads (Invitrogen) were resuspended in 20 ml Binding and Blocking buffer (10mM Tris,
250 mM NaCl, 5 mM EDTA, 0.5% SDS) and added to each well. After 15 min incubation at room temperature, all wells were pooled,
the beads washed once with 100 ml Washing buffer (10 mM Tris-150 mM NaCl, 0.02% Tween), once in 100 ml QIAGEN Qiaquick PB
and then twice using 100 ml Washing buffer. Restriction was performed to cleave 30 fragments: the beads were incubated in 100 ml
restrictionmix (1xNEBCutSmart, 0.4 U/ml PvuI-HF enzyme) for 1 hr at 37C. Finally, the beadswerewashed three timeswithWashing
buffer, then resuspended in 30 ml ddH2O and incubated for 10 min at 70
C to elute the DNA. AMPure beads XP (Beckman Coulter)
were used at 1.8x volume and eluted in 30 ml to remove short fragments.
Illumina sequencing and bioinformatics pre-processing
The molar concentrations of the libraries was determined with KAPA Library Quant qPCR (Kapa Biosystems) and size
distribution was evaluated after PCR (12cycles) using an Agilent BioAnalyzer. Sequencing was performed on an Illumina
HiSeq 2000 with C1-P1-PCR2 as read 1 primer and C1-TN5-U as index read primer. Reads of 50 bp as well as 8 bp index readse4 Cell 167, 566–580.e1–e10, October 6, 2016
corresponding to the cell-specific barcodes were generated. Reads were mapped using bowtie and processed as described
previously (Zeisel et al., 2015), adding the more strict criteria for UMI counting: we removed all singletons (molecules supported
by a single read).
hESC differentiation
Human ESC-derived dopaminergic neurons from H9 and HS401 cell lines were differentiated in a similar manner as Kriks et al.
(2011) (Figure S7A). hESCs were dissociated into single cells by TrypLE Select (Thermo Fisher Scientific) and were plated on re-
combinant human laminin-111 (BioLamina) coated plates at a density of 600,000 cells per cm2 in Glasgow’s minimum essential
medium (G-MEM) supplemented with 8% knockout serum replacement (KSR), 0.1 mM MEM nonessential amino acids, sodium
pyruvate, and 0.1 mM 2-mercaptoethanol (all Thermo Fisher Scientific). Differentiation mediumwas gradually shifted to neurobasal
medium with B27 supplement (Thermo Fisher Scientific) and 2 mM L-glutamine (Thermo Fisher Scientific) from day 5 to day 12.
LDN193189 (100 nM; Stemgent) and SB431542 (10 mM; Tocris) were supplemented from day0, SHH C-24 (200 ng/mL; R&D)
and fibroblast growth factor 8 (FGF8b; 100 ng/mL; R&D) were supplemented from day1, and CHIR99021 (3 mM; Sigma) was sup-
plemented from day3. SB431542 and FGF8b were removed from the culture medium on day 7. Y-27632 (10 mM, Tocris) was sup-
plemented for 24 hr after single cell dissociation. Cells were dissociated using TrypLE Select and replated on ornithine (50 mg/mL;
Sigma) / fibronectin (2 mg/mL; Sigma) / laminin (3 mg/mL; Thermo Fisher Scientific)-coated plate at a density of 300,000 cells per
cm2 in neurobasal medium supplemented with B27 supplement and 2 mM L-glutamine, GDNF (10 ng/mL; R&D), ascorbic acid
(200 mM; Sigma), BDNF (20 ng/mL; R&D), 400 mM dbcAMP (0.5 mM; Sigma) and TGFb3 (1 ng/mL; R&D) on day 12 and day 19.
Culturemediumwas changed every 2-3 days. At day 0, 12/13, 18/19 and 35 cells from replicate wells were used for: qPCR analysis,
4% paraformaldehyde fixation for immunohistochemistry, and single-cell dissociation for RNA-seq using TrypLE Select and
collecting in culturing media.
iPS derived dopaminergic neurons
iCell DopaNeurons were thawed and cultured in 48 well-plates previously coated with poly-L-ornithine (Sigma) and Laminin (Sigma).
The plating density of the cells was between 120,000-160,000 cells/cm2 in four different experiments. The cells were incubated at
37C, 5% CO2, for 5 and 21 days, with iCell DopaNeurons Maintenance Medium (DNM-301121001) complemented with iCell
DopaNeurons Medium Supplement (DNM-301031001) and iCell Nervous System Supplement (NSS-301031001) provided by
Cellular Dynamics Int. At two different time points, day 5 and day 21, some wells were fixed with 4% paraformaldehyde and used
for immunohistochemistry and the rest of thewells were used for single-cell RNA-seq analysis; after trypsinizationwith TrypLESelect,
cell resuspension was kept in the same maintenance medium with albumin from bovine serum.
Reverse transcription and qPCR
Total RNA was extracted using an RNeasy Mini kit (QIAGEN). 200-500 ng of total RNA was used for reverse transcription by a Super
Script II First-Strand Synthesis System with random primer (Invitrogen). qPCR was performed by using a StepOne detection system
(Applied Biosystems). Data analysis is based on the DDCT method with normalization of the raw data to GAPDH genes. Primer se-
quences are shown in Table S4.
Immunohistochemical analysis
After mouse embryos (E12.5-E18.5) or postnatal brains were fixed in 4% paraformaldehyde for at least 6 hr, they were processed in
30% sucrose and embedded in OCT (Tissue Tek) then cryostat sectioned at 16mm. Human fetal tissue for cryosectioning was im-
mersion-fixed overnight in 4% paraformaldehyde at 4C, then cryoprotected in sucrose before embedding in OCT compound,
then 14 mm sections were cut using a Leica cryostat. According to manufacturer’s antibody recommendations, some sections
were treated for antigen retrieval by microwave boiling (S1699, DAKO). Sections were washed in PBS and incubated in blocking so-
lution, PBTA (PBS, 5% normal donkey serum (Jackson ImmunoResearch), 1% BSA, 0.2% Triton X-100). Sections were incubated
overnight at 4C in primary antibody. Slides were washed and then incubated for 1-2 hr at room temperature with corresponding
Alexa Fluor fluorophore-conjugated secondary antibodies and nuclei counterstained using DAPI.
For hiPSC and hESC in vitro cultures, after incubation for 1 hr in blocking solution, the cells were incubated overnight at 4Cwith a
series of combinations of different primary antibodies. After removal of the primary antibodies, wells were washedwith PBS and incu-
bated for 1 hr with corresponding secondary antibodies and nuclei counterstained.
Image capture was done with Zeiss LSM700, Zeiss LSM780 or Olympus FV1000 at CLICK facility. Images were processed with
Adobe Photoshop and Illustrator.
In situ hybridization
For in situ hybridization, embryos at E12.5 and E13.5 were fixed (4% paraformaldehyde, 4C) overnight then cryopreserved in 30%
sucrose and embedded in OCT for sectioning, 14 mm. Sequences for primers for the production of mouse antisense RNA probes
were obtained from Allen Institute for Brain Science, and are given in the Key Resources Table. In situ hybridization was performed
using Digoxigenin-labeled probes and detection with alkaline phosphatase-conjugated antibody, as described previously (Conlon
and Herrmann, 1993). Briefly, 4% paraformaldehyde preserved and cryo-embedded embryos were sectioned coronally at 14 mm.Cell 167, 566–580.e1–e10, October 6, 2016 e5
Probes were synthesized with DIG RNA and SP6 polymerase and hybridized to sections overnight at 70C. After thorough washing
and blocking, anti-Digoxigenin-AP Fab fragments were incubated on slides overnight at 4C. After washing, slides were developed
using NBT/BCIP solution. Where indicated, in situ images were resourced from Allen Institute for Brain Science: Allen Mouse
Brain Atlas (Lein et al., 2007) and Allen Developing Mouse Brain Atlas. Available from: http://mouse.brain-map.org and http://
developingmouse.brain-map.org, respectively.
Single molecule RNA FISH
RNA smFISH was carried out as previously described (Zeisel et al., 2015) with minor modifications. 10 mm thick sections of E11.5,
E13.5 and 15.5 embryos were mounted on the same cover glass, post-fixed with 4% paraformaldehyde for 10 min at room temper-
ature and permeabilizedwithmethanol. In order to perform sequential hybridization, the cover glasswasmounted on a custom-made
imaging chamber. After assembly, the chamber was incubated for 10 min at 70C in Tris-EDTA (pH 8.0). The sections were then
washed twice with SSC 2X and incubated with hybridization buffer containing 250 nM fluorescent label probes (LGCBiosearch Tech-
nologies) for 4 hr at 38.5C. After four 20% formamide-SSC 2X washes, the slides were counterstained with Hoechst, washed with
SSC2X and imaged in Slow Fademountingmedium (Thermo Fisher Scientific). Image stacks (0.3 mmdistance) were acquired using a
Nikon Ti-E motorized inverted microscope. After imaging, the hybridized probes were stripped in 65% formamide and washed three
times in 2X SSC. The sections were re-imaged in order to confirm that no probe signal was detectable. The hybridization-imaging-
stripping procedure was then repeated two more times. Sequences of probes for all genes are found in Table S3.
The images were analyzed using the Python numpy, scipy.ndimage (Jones et al., 2014) and scikit-image (van der Walt et al., 2014)
libraries. Briefly, after background removal using a large kernel Gaussian filter, a Laplacian-of-Gaussian was used to enhance the
RNA dots. Background objects significantly larger (60 times the area) than the smFISH dots were removed after image thresholding.
The images were then stitched, aligned, and pseudocolored in Fiji (Schindelin et al., 2012). To facilitate visualization the size of dots
was increased using a dilation filter.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quality control
Taking in to consideration the distribution of molecules per cell in each dataset we set both a lower and an upper threshold (2000-
26000 molecules/cell for mouse embryo cells, 2000-30000 molecules/cell for adult mouse cells, 1200-24000 molecules/cell for the
human embryo cells and 2200-13000molecules/cell for the hPSCs) so that we could eliminate cells outside of this range with the aim
of removing data from both broken cells and doublets that might have gone undetected despite the imaging. We further decided to
exclude cells that had inconsistent assignment with different BackSPIN parameters and lowmolecule count. For the hiPSCs and the
hESCs this last step of filteringwas not performed since it may introduce bias when estimating the abundance of different kind of cells
present in the culture. Genes that were detected at less than 4 molecules in the whole datasets were eliminated. After these quality
control procedures, we were left with: 1907 cells for the mouse embryo dataset with detected transcripts between 929 and 6063
(median 2831); 1977 cells from the human embryos with detected transcripts between 717 and 5459 (median 2292); 279 cells
from the adult mouse with detected transcripts between 1445 and 6498 (median 4033); 337 cells from the hiPSC culture with de-
tected transcripts between 983 and 4411 (median 2284) and 1715 cells from the hESC culture with detected transcripts between
959 and 7110 (median 3635).
Clustering and cluster analysis
Cells were clustered using a version of the BackSPIN algorithm optimized for this dataset. We used a Bayesian generalized linear
model (GLM) to assign every gene to one or more cell populations, as previously described (Zeisel et al., 2015). We used BackSPIN,
an iterative clustering approach that alternates feature selection and clustering. Briefly, we first selected genes with the highest vari-
ation and then we ran BackSPIN with low splitting depth to reveal major splits in the data. (e.g., vascular, neurons, cycling cells). We
then undertook a further feature selection on each of these high level clusters and we reclustered them to resolve finer differences. In
this way, we avoided the initial feature selection imposing a subspace that would mask biologically relevant differences.
The feature selection procedure is based on the largest difference between the observed coefficient of variation (CV) and the pre-
dicted CV (estimated by a non-linear noise model learned from the data) See Figure S1C. In particular, Support Vector Regression
(SVR, Smola and Vapnik, 1997) was used for this purpose (scikit-learn python implementation, default parameters with gamma =
0.06; Pedregosa et al., 2011). Importantly, after defining two clusters A and B, we used a procedure to avoid considering genes
peculiar to B when reclustering A and vice versa. This is undesirable because it could result in calling spurious clusters as a result
of carryover or occasional contamination.
The procedure was performed as follows: (1) Starting with the set of genes assigned byBackSPIN to B (2)We refined it by defining a
core set of genes highly correlated (3) We then searched among all the genes the ones that were highly correlated with most of the
core genes, (4) and excluded all the genes so identified when reclustering A.
The steps of the BackSPIN algorithm (Zeisel et al., 2015) are described in detail below.
For the analysis of the human dataset we proceeded as follows. (1) We performed a first feature selection and then ran Back-
SPIN. At this level cell-cycle genes had an important effect on clustering, making it more difficult to separate cell types. Therefore,e6 Cell 167, 566–580.e1–e10, October 6, 2016
we removed cell-cycle genes with the procedure described above and analyzed cell-cycle state separately (see below). (2) We
performed a feature selection of 2000 genes and ran BackSPIN clustering on the whole dataset. Clustering revealed a major split
between non-neural and neural cells. (3) We then proceeded with the clustering of the neuronal cells finding a major separation
between ventricular zone cells and neuroblast/neurons. (4) Each of these subclusters were then clustered at high depth (numLe-
vels = 7, runs_iters = 12, runs_step = 0.1, stop_const = 1.1). The clustering of the mouse was performed following the same
procedure.
To avoid unreliable splits, we manually inspected the clustered matrix and rejected those splits that did not show obvious gene
expression differences, and reconstituted the cluster at the previous level. This adjustment thus resulted in more conservative clus-
ters in some cases, but never resulted in the creation of new clusters not supported by the algorithm.
To visualize the high dimensional data in two-dimensional space and to validate our clustering result we used t-stochastic neighbor
embedding (t-SNE; der Maaten and Hinton, 2008). As a fair comparison, we calculated t-SNE projection using the same 2000 genes
that were used as the initial input in the BackSPIN algorithm.
Adult mouse dopaminergic neuronal data were clustered together with dopaminergic neurons from the embryonic dataset to allow
clusters including both the embryonic and adult cells (however, the difference was clear and BackSPIN separated these two datasets
with great fidelity). In this analysis, similar to what we had described before for the iterative BackSPIN we filtered away genes that
were significantly higher in other cell types in the adult VM (p < 0.005) and selected fewer genes (100) for the BackSPIN clustering.
Similarities between clusters within a species were summarized using a Pearson’s correlation coefficient calculated on the binar-
ized matrix (Figures 1C and 1D). For the calculation all genes that were significantly expressed over baseline levels in at least one of
the clusters were used, but if a gene was detected at less than 1 molecule per cell in all the clusters, it was excluded from the calcu-
lation. Correlation matrices were then sorted by SPIN (Tsafrir et al., 2005) for easier visualization.
BackSPIN Algorithm
BackSPIN is a two-way clustering algorithm crafted to handle large datasets and developed taking into account intrinsic features of
single-cell RNA-seq experiments. BackSPIN uses SPIN (Sorting Points Into Neighborhoods, Tsafrir et al., 2005) as the engine for sort-
ing correlation-based distance matrices in a one-dimensional order. Briefly, SPIN sorts a distance matrix by iteratively permuting
rows (or columns) while maximizing an objective function that penalizes the separation of similar rows (or columns).
BackSPIN extends SPIN by implementing a splitting procedure to divide the sorted data matrix into sub-matrices that finally yield
coupled clusters of cells and genes.
Let A be a matrix (m x n) typically containing gene expression where columns represent cells and rows genes. The aim is to obtain
clusters of cells (columns) with their corresponding overexpressed/enriched genes. The algorithm is composed of two main
functions:
(1) A SPIN-sorting of a correlation matrix: returning a permutation (one dimensional order) that optimizes the SPIN objective func-
tion (Tsafrir et al., 2005).
(2) A splitting step. Allowing for C to be the sorted correlation matrix from the previous step, it finds the optimal splitting point xs
such that it maximizes an objective function defined as:
fðxÞ=
Px
i = 0
Px
j = 0
Ci;j +
Pn
i = x + 1
Pn
j = x+ 1
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x
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The steps of the algorithm are as follows:
STEP1: Sort the samples (cells) correlation matrix C iterating SPIN with gradually decreasing width parameter.
STEP2: Find xs and divide the matrix A in two sub-matrixes K and L. For each gene, the two sub-matrixes are considered in the
orientation that maximizes the distance of their center of mass from the point of split. Then, the center of mass over the parent matrix
is calculated and the gene assigned to the cluster of cells this falls in.
STEP3: If f(x) is greater than a threshold (stopping condition) repeat STEP 1 and 2 for K and L. When f(x) is smaller than a threshold
or max splitting depth is reached, then stop splitting.
STEP4: SPIN-sort the samples and construct a features correlation matrix of every sub-matrix generated.
The rationale for using the center-of-mass for assigning genes to sub-matrices is as follows. Once thematrix A has been split in two
sub-matrices K and L, the goal is to assign each gene to either K or L. A statistical test could be used to determine, for example, if the
gene is expressed at a higher level in K than in L, or vice versa. However, it may be that the gene is truly expressed only in a small
subset of the cells in K, whereas it has a broad low-level expression in all cells in L. Thus the gene is more relevant for subsequent
clustering of K than of L. But since both K and L are ordered by SPIN (the first step in each BackSPIN iteration), we can detect such
expression in a small (and correlated) subset of cells by using the center of mass. In a sense, the center of mass lets BackSPIN peek
into the future and detect clusters of cells that will only be discovered in later iterations. The key feature of center-of-mass is that it
exploits the correlation-based ordering of cells, which provides a signal that a gene is relevant for defining subsets of cells in future
iterations of the algorithm. In contrast a two-group statistical test will simply reveal which group has a higher expression, not which
group has a more structured and informative expression of the gene.Cell 167, 566–580.e1–e10, October 6, 2016 e7
Marker discovery and binarization by Bayesian regression
We used a Bayesian generalized linear model (GLM) to assign every gene to one or more cell populations. The GLM models the
measured gene expression of a cell as realizations of a Negative Binomial probability distribution whose mean is determined by a
linear combination of K predictors xi with coefficient bi.
m=
XK
k= 1
bkxk k˛½1;K
For each cell, the outcome and predictors are known and the aim is to determine the posterior probability distributions of the
coefficients.
As predictors, we use a continuous Baseline predictor and a categorical Cell Type predictor. The Baseline predictor value is the
cell’s molecule count normalized to the average molecule count of all cells and takes account of the fact that we expect every
gene to have a baseline expression proportional to the total number of expressed molecules within a particular cell. While the Cell
Type predictor is set to 1 for the cluster BackSPIN assignation of the cell, and 0 for the other classes. From the definition of the model
it follows that the coefficient bk for a Cell Type predictor xk can be interpreted as the additional number of molecules of a particular
gene that are present as a result of the cell being of cell type k. A more detailed description of the model, including explanation of the
prior probabilities used for the fitting as well as the full source code of the model, is provided elsewhere (Zeisel et al., 2015). The Stan
(http://mc-stan.org) source is copied below for completeness:
data {
int < lower = 0 > N; # number of outcomes
int < lower = 0 > K; # number of predictors
matrix < lower = 0 > [N,K] x; # predictor matrix
int y[N]; # outcomes
}
parameters {
vector < lower = 1 > [K] beta; # coefficients
real < lower = 0.001 > r; # overdispersion
}
model {
vector < lower = 0.001 > [N] mu;
vector < lower = 1.001 > [N] rv;
# priors
r cauchy(0, 1);
beta pareto(1, 1.5);
# vectorize the overdispersion
for (n in 1:N) {
rv[n] < - square(r + 1) - 1;
}
# regression
mu < - x * (beta - 1) + 0.001;
y neg_binomial(mu ./ rv, 1 / rv[1]);
}
To determine which genes are higher than basal expression in each population we compared the posterior probability distribu-
tions of the Baseline coefficient and theCell Type coefficient. A gene was considered asmarking a cell population if (1) its cell-type-
specific coefficient exceeded the Baseline coefficient with 99.8% (95% for the mouse adult) posterior probability, and (2) the
median of its posterior distribution did not fall below a threshold q set to 35% of the median posterior probability of the highest
expressing group, and (3) the median of the highest-expressing cell type was greater than 0.4. For every gene this corresponds
to a binary pattern (0 if the conditions are not met and 1 if they are), and genes can therefore be grouped according to their binarized
expression patterns.
We use those binarized patterns to call transcription factor specificity. Our definition of a transcription factor gene was based of
annotations provided by the merged annotation of PANTHER GO (Mi et al., 2013) and FANTOM5 (Okazaki et al., 2002), this list was
further curated and missing genes and occasional misannotations corrected.
Cross-species comparison
First we used the Bayesian model described above to obtain for every gene theMaximum a posteriori (MAP) estimate of the cell-type
specific mean parameter. To make the gene expression profiles of mouse and human cell types comparable we used the homology
correspondences provided by the Homologene database (Wheeler et al., 2007). We considered only the biunivocal correspon-
dences, while the one-to-many correspondences (constituting a minority of the database) were discarded.e8 Cell 167, 566–580.e1–e10, October 6, 2016
With the datasets in the same feature space, it is possible to calculate a similarity measure between cell types of different species.
We found that, in this context, a naive correlation coefficient calculated over the full transcriptomewas biased to assign high similarity
because of confounding factors such as size or number of expressed genes. We therefore further filtered the feature space to reduce
it to the genes that were expressed with some significant variation across the cell types. This was defined using the following filter:
select genes that are (1) significantly expressed (according to the Bayesian condition described above) over baseline in at least one
cell type in both species but (2) in less than 6 cell types in at least one of the species and (3) with amaximal expression that was bigger
than 1.5 molecules per cell and the smaller than 0.25 in either species. 1405 genes passed this filter and were used for the calculation
of the correlation coefficient.
Two cell types were considered to be correspondent when they satisfied the following condition:
Sn;mRSn;j cj˛fMm celltypes g^ Sn;mRSi;m ci˛f Hs celltypes g
Where Sm,n is the correlation between a human cell type m and mouse cell type n.
For the time comparison, we estimated the time when half of all the cells sampled had been observed. We estimated this quantity
by first fitting a continuous smooth function to the time points and then finding the point where the area under the curve was half of the
total.
Proliferation index
We developed a cell-cycle scoring approach that uses expression data to compute an index for every cell that scores the cell ac-
cording to its expression of cell-cycle genes. In brief, our approach proceeded through four steps. (A) We reduced dimensionality
of the dataset to the cell-cycle relevant genes. (B) In this subspace we performed, as a first approximation, a simple K-means clus-
tering to separate non cycling from cycling cells and (C) we used this clustering as a reference to learn a function that takes the gene
expression as the input and returns a cell-cycle score as an output. (D) We used this function to calculate a score for each single cell.
We started by selecting a wide selection of genes related to cell-cycle and proliferation. We used the PANTHER GO database and
selected all the genes that were described by one of the following terms:DNAmetabolic process, DNA replication, mitosis, regulation
of cell cycle, cell cycle, cytokinesis, histone, DNA-directed DNA polymerase, DNA polymerase processivity factor, centromere DNA-
binding protein. We restricted our features to those genes. Genes that were detected at less than 10 molecules in the dataset were
removed. We calculated the pairwise correlation coefficient matrix, and selected the genes that were strongly correlated (99th
percentile of the matrix) with at least 12 other genes. The genes passing the filters described above were used for clustering cells
using K-means (Python scikit-learn implementation, on log-centered data, default parameters) with the rationale that the main
axis of variation expected would span across dividing and non-dividing cells. Then a linear regression model with L1-norm regula-
rization was fitted that used a learning function which took expression data of a cell and categorized into two classes, 1 when a cell
belongs to the cycling cluster and 0 when it did not. Importantly, to avoid both overfitting the score on the first approximation clusters
and also to obtain a more generalizable model, we used a strong regularization (5 times the one determined by cross-validation;
alpha = 0.01).
This procedure was used for both the mouse and human embryonic dataset. The function learnt on the human embryonic dataset
was also used to determine the proliferation index of the hPSCs.
Pseudotime analysis
We analyzed the variation of gene expression over time in the spirit of the recent work by Magwene et al. (2003) and Trapnell et al.
(2014). However we used a different algorithmic approach exploiting the mathematical properties of principal curve, which can be
considered a nonlinear generalization of a linear principal component (Hastie and Stuetzle, 1989). In brief, the principal curve is a
smooth one-dimensional curve that passes through the middle of a data cloud in n-dimension space. Therefore, the use of principal
curve does not require reducing dimensionality down to 2 dimensions or building a graph. Noticeably, using principal curves we did
not have to artificially force our time path to pass through every cell point. Our approach consisted of the following steps: (1) Finding a
subspace that was time relevant. First, we selected the top 5000 genes using the CV-mean relation and thenwe testedwhich of those
genes varied significantly in time (embryonic day of sampling). We used an approach that conceptually corresponds to performing an
ANOVA for over-dispersed data: we performed a likelihood ratio test comparing a GLM with a Negative binomial link function and
time (E-day) as a categorical predictor against the null model that does not take time in account. Only significant genes (FDR <
0.01) were considered for the following steps. We also excluded genes that were significantly expressed in other cell types but
not in the cell type of interest. (2) We projected data using PCA and we selected the principal components that had a SD bigger
than 0.25. Finally, we calculated the principal curve passing through the points in this multidimensional space (using the R package
princurve; Weingessel andWeingessel, 2015). At this point, the curve could be projected back into the original gene space and by so
doing offer insight on the variation of genes in time. However, this can be done only for the original time-relevant features taken in to
account for the PCA calculation. So to make it possible to generalize it for every gene we projected every cell on the curve and as-
signed to every cell a principal time, corresponding to the length of the arch from the beginning of the curve. In this way, every gene
could be represented as a function of pseudotime. (3) We then fitted a curve pseudotime-expression using SVR (parameters where
chosen by crossvalidation using a stratified KFold procedure). Before fitting, the normalized molecule count data were corrected for
missing values using a Lasso regression approach described elsewhere (Satija et al., 2015). (4) The pseudotime dependent profile forCell 167, 566–580.e1–e10, October 6, 2016 e9
every gene was clustered using affinity propagation. Geneswith R-squared smaller than 0.35 were considered not significant and not
included in the clustering. This procedure resulted in a set of prototypical dynamics. The top genes ranked by the coefficient of deter-
mination (R-squared) of the prediction presented are shown in Figure S6A.
Cell scoring using machine learning
For the analysis on in vitro-derived cells (Figure 7), our goal was to score the molecular identity of each cell relative to in vivo-defined
cell types. For this purpose, we first calculated cell-type prototypes representing the idealized in vivo expression patterns. These
prototypes were then used as references to which individual cells could be compared, resulting in a probabilistic similarity score.
A logistic regression with L2-norm regularization and a multinomial learning approach (implemented by the scikit-learn function
LogisticRegression; (Pedregosa et al., 2011)) was trained using the log-transformed max-normalized data. As a training data for
the classifier, we used the human embryonic dataset, including, as a relevant outgroup, the early hESC data (day 0 of the in-vitro
differentiation experiment). We trained the model to learn more general cell-type prototypes, rather than restrict itself to the 25 clus-
ters. Prototypes consisted of either a single cluster (for example Serotonergic prototype is learnt on hSert) or by several subclasses
that are biologically related (the Dopaminergic prototype is learnt from hDA0, hDA1 and hDA2). The composition of the prototypes
consisting of more cell clusters were: Embryonic stem cells (eES) consisting of eSCa, eSCb and eSCc. Floor plate progenitors
(ProgFP) consisting of hProgFPM, hProgFPL and hProgM. Radial glia (Rgl) consisting of hRgl1, hRgl2, hRgl2b, hRgl2c and hRgl3.
GABAergic lineage consisting of hNbML5, hNbGaba and hGaba.
To train the model, the top 4500 most variable genes were chosen by CV-mean relation as above, and refined as follows: (1) To
avoid learning cell culture specific features instead of ES features we discarded genes that had minimal variability in the whole
hESC differentiation experiment when compared to the combined dataset (2) To eliminate genes whose variation is orthogonal to
cell-types and produce amore general model the gene list was further reduced to half. We did this by choosing the top genes ranked
by three heuristics for cell-type specificity (fold-increase, fold-increase*fraction-positive, fold-increase* fraction-positive0.5) (Mar-
ques et al., 2016).
To choose the adequate regularization parameter for the logistic regression, the classifier accuracy and sum of regression coef-
ficients were plotted against progressively less stringent regularization parameters and inspected (Figures S7H and S7I). The value of
regularization (C = 0.01) was chosen as it corresponds to the point that has maximum accuracy before the plateau is reached. The
average accuracy was estimated by a cross-validation procedure: for 35 iterations the dataset was randomly split (following a strat-
ified k-fold approach) the bigger part (85% of the dataset) was used to train the classifier and the remaining 15% was used as a test
set to compute the accuracy score (fraction of correctly predicted sample over the total).
Finally, the model was used to predict the probabilities of each cell belonging to each one of the prototype classes, the predicted
probability of each class is calculated using the softmax function (implemented by the predict_proba method of the logistic regres-
sion model, scikit-learn).
Data were plotted on a ‘‘wheel plot’’ polygon by calculating the position of each cell as a linear combination weighted by the prob-
abilities emitted by the model. That is: let pi be the probability of a cell belonging to prototype class i and let bui be the unitary vector of
origin the center of the polygon and directed toward the ith vertex of the polygon, the position xi
!
is, then, given by: xi
!
=
P
pi bui. To
make this representation clearer and more informative, the order of the vertices was chosen to minimize the number of cells in the
central area of the plot.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The accession number for the raw data reported in this paper is GEO: GSE76381.
Cell-scoring command-line tool and ipython notebooks showing key steps of the analysis are available for download on Github
at: http://github.com/linnarsson-lab/ipynb-lamanno2016. BackSPIN algorithm is available on Github: https://github.com/
linnarsson-lab/BackSPIN.
ADDITIONAL RESOURCES
Plots for any gene can be visualized at http://linnarssonlab.org/ventralmidbrain.e10 Cell 167, 566–580.e1–e10, October 6, 2016
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Figure S1. Quality Control of Single-Cell Rna-Seq, Related to Figure 1
(A) Distribution of number of mRNA molecules detected in human cells.
(B) Distribution of number of mRNA molecules detected in mouse cells.
(C) Plot of CV (coefficient of variation, i.e., SD divided by the mean) versus mean mRNA molecule counts. Grey dots, genes; red line, Poisson distribution; black
curve, fit of noise distribution used to select genes with greater than expected CV.
(D) Scatterplot showing genes expressed in two human cells of the same type.
(E) Scatterplot showing genes expressed in two human cells of different types.
(F) Scatterplot showing genes expressed in two mouse cells of the same type.
(G) Scatterplot showing genes expressed in two mouse cells of different types.
(H) Pie chart showing the cell type composition of mouse cell types, all time points combined (excluding adult).
(I) Pie chart of human cell types as in (H).
(J) Replicate experiments supporting each cell type in mouse. Box and whiskers plots showing the expected distribution of a perfectly random sampling pro-
cedure, estimated by repeatedly scrambling the gene labels. (box Q1-Q4; whiskers: 95% C.I.). Green dots show actual sampled data.
(K) Replicate experiments supporting each cell type in human. Box and whiskers as in (J)
(L) Heatmap showing the overlap of BackSPIN and Affinity Propagation clusters for the human dataset.
(M) Heatmap showing the overlap of BackSPIN and Affinity Propagation clusters for the mouse dataset.
Figure S2. Violin Plots Showing a Selection of Genes with Specific Expression in Specific Human Cell Types, Related to Figure 1
Each row shows violin plots depicting posterior probability distributions for the expected mean expression, one for each cell type. Grey boxes indicate > 99.8%
probability of expression above baseline (STAR Methods). Genes are grouped for clarity. A full set of genes is provided in Table S2.
Figure S3. Violin Plots Showing a Selection of Genes with Specific Expression in Specific Mouse Cell Types, Related to Figure 1
As in Figure S2.
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Figure S4. Transcription Factor Expression across Mouse and Human Cell Types, Related to Figure 1
(A) The binarized expression of transcription factors in human embryos. Rectangles are drawn below single or multiple cell types to represent binary patterns of
expression. For each pattern, the names of the transcription factor genes expressed above baseline levels are indicated.
(B) The binarized expression of transcription factors in mouse embryo.
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Figure S5. Radial Glia Single Molecule RNA FISH, Related to Figure 3
(A) Representative images corresponding to the diagram in Figure 3D. For clarity, every cell type was identified unambiguously by the expression of two genes
and by the non-expression of two other genes. All images correspond to a field of size 13mm 3 13mm.
(B) Schematic of cell types at different sampled time points.
Figure S6. Oculomotor and Trochlear, Serotonergic, and Dopaminergic neurons, Related to Figure 4 and 6
(A) Examples of genes regulated along pseudotime in mOMTN. No genes were significantly downregulated.
(B) Validation of the induction of Pvalb during maturation of mOMTN, shown alongside Isl1 in sagittal sections of mouse embryos (in situ hybridization data from
the Allen Developing Mouse Brain Atlas) (scale bars 200 mm).
(C) Violin plots showing the expression of key genes involved in serotonergic synapse function, across all human cell types.
(D) Violin plots showing the expression of key genes involved in serotonergic synapse function, across all mouse cell types.
(E) Schematic of the function of genes in (C/D) in a serotonergic neuron, here drawn in place of their corresponding protein products (adapted from Deneris and
Wyler, 2012).
(F) Spatial distribution of the five adult dopaminergic cell types (in situ hybridization data from Allen Mouse Brain Atlas) (scale bars 200 mm).
(G) Validation of AJAP1 as a pan-dopaminergic marker in the adult mouse brain (scale bar left 100 mm; scale bar right 20 mm).
(H) Scatterplots showing the level of expression of genes expressed above baseline in matching cell types (left) and the correlation of the cell types that express
the genes at higher levels (right)
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Figure S7. Stem Cells Differentiation Protocol and Machine Learning Performance and Diagnostics, Related to Figure 7
(A) Schematic of the hESCs in vitro differentiation protocol.
(B) Variation of expression of marker genes during the differentiation protocol measured by qPCR. As a comparison, values calculated by summing single cell
expression levels are shown as dashed line.
(C) Immunostaining of hESC cultures (scale bar 50 mm).
(D) Immunostaining of hiPSC cultures (scale bar 50 mm).
(E) Heatmap showing raw hiPSCs data clustered. Columns are single cell and rows genes. Cell clusters and genes enriched in every cluster are surrounded by red
boxes.
(F) Heatmap showing raw hESCs data as in (E).
(G) Violin plots showing proliferation index distribution for each hiPSC and hESC cluster.
(H) Line plot showing the accuracy score of the classifier varying with decreasing regularization strength as estimated by cross-validation. Red line shows 95%
C.I. on the estimation of the accuracy score.
(I) Line plot showing the total absolute values of weights. Blue vertical line in (H-I) shows the chosen regularization parameter.
(J) Training dataset plotted on wheel plot as in Figure 7G.
(K) Score distribution on the training dataset clusters.
(L) Negative control cells are obtained by scrambling gene values of cells of the training dataset and are plotted on wheel plot as in Figure 7G.
(M) Histograms showing classifier scores of single cells belonging to the human dopaminergic clusters (left), to the dopaminergic hiPSC clusters (center) and to
the rest of the cells in the hiPSC preparation (right).
